Filter
2243
Filtered Results: 2243
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
254
New Publications
713
Language
Document type
No document type
1345
Guidelines
330
Studies & Reports
286
Manuals
120
Strategic & Response Plan
105
Training Material
24
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
157
Kenya
77
Global
67
South Africa
64
Nigeria
59
Uganda
54
Nepal
48
Sierra Leone
46
Tanzania
45
Western and Central Europe
44
Ghana
41
Zambia
38
Myanmar / Burma
37
Ethiopia
36
Malawi
35
Bangladesh
31
Liberia
31
Namibia
27
Africa
25
Lesotho
19
Eastern Europe
19
South–East Asia Region
18
Rwanda
16
Zimbabwe
16
Cambodia
15
Asia
14
Latin America and the Carribbean
13
Botswana
13
Ukraine
12
Syria
12
Philippines
12
Congo, Democratic Republic of
10
Indonesia
10
Russia
8
Tajikistan
7
Cameroon
7
South Sudan
7
Eswatini/ Swaziland
7
Albania
6
Senegal
6
West and Central Africa
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
East and Southern Africa
6
Pakistan
6
Thailand
5
Burkina Faso
5
Middle East and North Africa
5
Laos
4
Guinea
4
Mozambique
4
Afghanistan
3
Germany
3
Sudan
3
Georgia
3
Iraq
3
Benin
2
China
2
Kyrgyzstan
2
USA
2
Haiti
2
United Kingdom
2
Brazil
2
Sri Lanka
2
Bhutan
2
Somalia
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Singapore
1
Uzbekistan
1
Peru
1
Qatar
1
Bulgaria
1
Lithuania
1
Jordan
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Lebanon
1
Vietnam
1
Moldova
1
Yemen
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
920
Clinical Guidelines
235
Public Health
143
Key Resources
105
Women & Child Health
104
Pharmacy & Technologies
40
Capacity Building
35
Toolboxes
HIV
254
TB
194
AMR
147
Mental Health
132
COVID-19
76
Pharmacy
75
NTDs
74
Caregiver
53
Rapid Response
49
NCDs
44
Ebola & Marburg
38
Planetary Health
33
Global Health Education
29
Conflict
28
Disability
24
Refugee
22
Health Financing Toolbox
11
Polio
11
Natural Hazards
10
Cholera
9
Specific Hazards
8
Zika
5
Malaria
2
Perspectives on Drugs
Harm reduction: evidence, impacts and challenges
-10-
Advance copy.
2018 monitoring report: current status and strategic priorities
The report sets out the status of women’s, children’s and adolescents’ health, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made o...
The report sets out the status of women’s, children’s and adolescents’ health, and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made o...
In view of the ongoing political, peace and reconciliation, administrative and economic reforms as well as plans to establish the United Nations Development Assistance Framework (UNDAF) in 2018, WFP extended the current Protracted Relief and Recovery Operation (PRRO 200299), launched in January 2.... To echo this extension and provide a more appropriate response to the country's rapid and multi-pronged transition, WFP adopted a transition strategy with gradually reduced emphasis on humanitarian assistance and greater focus on early recovery and development interventions. WFP's strategic engagement in-country was driven by the overarching goal to assist Myanmar to achieve the national Zero Hunger Challenge by 2025, and was guided by three priorities: emergency preparedness and response; nutrition; and provision of social safety nets.
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
tep 1 Competencies have been designed to provide staff with the core skills required to care for a critically ill patient safely, whilst under supervision. It is expected that Step 1 competencies will be completed prior to commencing an academic critical care programme.
Steps 2 & 3 Competencies hav...
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidance for the CO...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
